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Peripheral nerve injury triggers the activation of RhoA in spinal motor and peripheral
sensory neurons. RhoA activates a number of effector proteins including the
Rho-associated kinase, ROCK, which targets the cytoskeleton and leads to inhibition
of neurite outgrowth. Blockade of the Rho/ROCK pathway by pharmacological means
improves axon regeneration after experimental injury. C3bot transferase, an exoenzyme
produced by Clostridium botulinum, inactivates RhoA by ADP-ribosylation. It has been
successfully applied in experimental CNS lesions to facilitate axon regeneration. Up to
now it was not investigated thoroughly whether C3bot exerts positive effects on peripheral
axon regeneration as well. In the present study, recombinant membrane permeable C3bot
produced a small, but significant, axon outgrowth effect on peripheral sensory neurons
dissociated from adult dorsal root ganglia (DRG) of the rat. Neuronal overexpression of
C3, however, did not enhance axonal growth. Moreover, transfection of plasmids encoding
dominant negative RhoA or RhoA specific shRNAs failed to increase axonal growth.
Furthermore, we show that the C3bot mutant, C3E174Q, which lacks RhoA inhibitory
activity, still stimulates axonal growth. When analyzing possible signaling mechanisms we
found that extracellular signal-regulated kinase (ERK) and Akt are activated by C3bot and
ERK is induced by the C3E174Q mutant. Upregulation of kinase activities by C3bot occurs
significantly faster than inactivation of RhoA indicating a RhoA-independent pathway of
action by C3bot. The induction of ERK signaling by C3bot was detected in embryonic
hippocampal neurons, too. Taken together, although RhoA plays a central role for inhibition
of axon outgrowth by myelin-derived inhibitors, it does not interfere with axonal growth of
sensory neurons on a permissive substrate in vitro. C3bot blocks neuronal RhoA activity,
but its positive effects on axon elongation and branching appear to be mediated by Rho
independent mechanisms involving activation of axon growth promoting ERK and Akt
kinases.
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INTRODUCTION
Following a peripheral nerve lesion axon regeneration results in
restoration of function, but long distance regeneration continues
to remain amajor challenge. To this end, axon elongation needs to
be promoted over axon branching that leads to neuroma forma-
tion at the lesion site and misdirected regeneration into the distal
nerve stump (Grosheva et al., 2008). Small GTPases have been
suggested to play a key role in axon elongation and branching by
acting as intrinsic modulators of axon growth, either as positive
(Rac1, Cdc42) or negative (RhoA) regulators (for a recent review
see Auer et al., 2011). Peripheral nerve injury triggers the acti-
vation of RhoA in spinal motor and peripheral sensory neurons
(Hiraga et al., 2006; Cheng et al., 2008). RhoA primarily mediates
neurite retraction (Wahl et al., 2000), whereas Rac1A and Cdc42
induce lamellipodia and filopodia formation (Kozma et al., 1997).
Pharmacological inhibition of RhoA or expression of dominant
negative RhoA results in neurite outgrowth of neuronal cell lines
(Nishiki et al., 1990; Kranenburg et al., 1997; Albertinazzi et al.,
1998; Sebok et al., 1999).
RhoA activates several effector proteins including the Rho-
associated kinase, ROCK, which targets the actin, actomyosin,
and microtubule cytoskeleton resulting in retraction of growth
cones and blockade of neurite outgrowth (Govek et al., 2005;
Mimura et al., 2006). Some of the Rho/ROCK inhibitors show
beneficial effects in lesion models of the CNS and PNS. The
cell permeable form of C3bot (BA-210 or Cethrin®; McKerracher
and Higuchi, 2006), an exoenzyme produced by Clostridium
botulinum that inactivates RhoA by ADP-ribosylation (Aktories
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and Just, 2005), has been successfully applied in various central
nervous system lesion paradigms to improve axon regenera-
tion functionally and morphologically (Lehmann et al., 1999;
Dergham et al., 2002; Fischer et al., 2004). Recently, Cethrin®
has successfully completed a phase I/IIa clinical trial (Fehlings
et al., 2011). Similarly, the ROCK inhibitor HA-1077 (Fasudil®)
facilitates regeneration in the injured CNS (Dergham et al., 2002;
Fournier et al., 2003) and in the lesioned sciatic nerve (Hiraga
et al., 2006; Cheng et al., 2008). The two latter studies revealed
that ROCK inhibition improves peripheral nerve regeneration
by increasing axon numbers and amplitudes of distally evoked
compound muscle action potentials. Moreover, in recent stud-
ies small peptides derived from C3bot were shown to promote
axon regeneration and motor recovery in the lesioned central and
peripheral nervous system (Boato et al., 2010; Huelsenbeck et al.,
2012).
Here, we provide evidence that interfering with RhoA
by pharmacological inactivation, down-regulation, or by a
dominant-negative approach does not promote axon outgrowth
of peripheral sensory neurons obtained from adult dorsal root
ganglia (DRG). Membrane permeable C3bot, however, does exert
positive effects on axon elongation and branching, but these occur
Rho-independently, presumably by activation of the neuronal
extracellular signal-regulated kinase (ERK) and Akt signaling
pathways.
RESULTS
UPREGULATION OF RhoA ACTIVITY UPON DISSECTION OF DRG AND
COUNTERACTING EFFECT OF NEURONAL GROWTH FACTORS
RhoA-GTP pull down assays revealed 3-fold higher levels of
active RhoA 2 h after dissection of adult sensory neurons as
compared to 24 h after plating (Figure 1) corroborating acti-
vation of RhoA as observed recently in axotomized DRG in
vivo (Hiraga et al., 2006; Cheng et al., 2008). We treated DRG
cultures with neuronal growth factors FGF-2 or nerve growth
factor (NGF; each 100 ng/ml for 2 h), because they are strongly
induced at the lesion site, promote axon outgrowth (Hausott
et al., 2009) and inhibit RhoA activity in a neuronal cell line
(PC12; Nusser et al., 2002; Harada et al., 2005). We found
that RhoA-GTP levels were decreased by 45 and 51%, respec-
tively, suggesting that growth factor mediated inhibition of RhoA
may contribute to improved axon regeneration. Consequently,
we hypothesized that any other means to negatively interfere
with RhoA-GTP loading could have beneficial effects on axonal
growth as well. The RhoA inhibitor C3bot is well known from a
number of CNS studies to markedly promote regrowth of nerve
fibers and functional recovery (McKerracher and Higuchi, 2006).
Therefore, we applied C3bot to dissociated adult DRG neuron
cultures.
RECOMBINANT C3bot STIMULATES AXON OUTGROWTH
C3bot treatment of sensory neurons derived from adult rat DRG
for 24 h revealed a small, but statistically significant, positive axon
outgrowth effect. The length of the longest axon (maximal axonal
distance) increased by 12%, the total axonal length by 43% and
the number of axonal branch points per cell was elevated by
36% (Figure 2A). Analogous to growth factor treatments (Yip
et al., 1984), C3bot enhanced neuronal soma size (Figure 2B). The
mean area of vehicle-treated neuronal cell bodies (1551μm2) was
significantly smaller than of C3bot treated cultures (1887μm2)
suggesting that C3bot exerts a general trophic effect onto DRG
neurons.
NEURONAL OVEREXPRESSION OF C3bot DOES NOT IMPROVE AXON
OUTGROWTH
After treatment of sensory neurons with recombinant C3bot we
hypothesized that neuronal overexpression of C3bot would have
an even stronger effect on axonal growth due to easier access to
cytoplasmic RhoA. It was already known that C3bot overexpres-
sion is sufficient to ADP-ribosylate and, thereby, inhibit RhoA
in various cell lines and primary neurons (Bobak et al., 1997;
Moorman et al., 1999; Semenova et al., 2007). Overexpression
of pEGF-C3bot in cultured sensory neurons, however, did not
enhance axon growth (Figure 3A). The maximal axonal distance
even decreased by 22%, whereas the total axonal length and the
number of branch points were not altered in C3bot transfected
neurons. Grouped cell RT-PCR revealed strong C3bot mRNA
expression in C3 overexpressing neurons (Figure 3B). Due to
the low transfection efficiency in primary neurons C3bot pro-
tein levels were assessed in the two cell lines, PC12 and SY5Y.
The protein was clearly detected in Western blotting exper-
iments following overexpression of C3bot (Figure 3C), which
also induced neurite outgrowth in PC12 cell cultures (data not
shown).
FIGURE 1 | RhoA-GTP pull down assays performed 2h or 24 h after
dissociation and plating of adult DRG neurons on a growth promoting
substrate (A). Compared to the 24h time point vehicle-treated naïve neurons
reveal significantly increased RhoA-GTP levels after 2 h in vitro, which is
counteracted by treatment with neuronal growth factors like FGF-2 or NGF
(B; each 100 ng/ml for 2 h; n = 3, mean ± SD; ∗p < 0.05).
Frontiers in Cellular Neuroscience www.frontiersin.org October 2012 | Volume 6 | Article 43 | 2
Auer et al. Rho-independent signaling by C3
FIGURE 2 | Application of the Rho inhibitor C3bot (1μg/ml, membrane
permeable) for 24 h increases the length of the longest axon
(maximal axonal distance), the extension of the axonal tree (total
axonal length), and the number of branch points per neuron (A; total
number of neurons per group >240, three independent experiments,
mean ± SEM; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.005). Histograms reflecting
the size distribution of cultured rat DRG neurons (B). DRG neurons with a
cell body area spanning less than 1500μm2 are classified as small DRG
neurons, those above 1500μm2 as large DRG neurons (separated by a
vertical line).
DOMINANT NEGATIVE RhoA MUTANTS AND shRNAs AGAINST RhoA
HAVE NO EFFECT ON AXON OUTGROWTH
The lack of effect of neuronal C3bot overexpression prompted
us to interfere with neuronal RhoA expression directly. Four
different shRNA sequences specifically targeting RhoA mRNA
were analyzed in comparison to scrambled control shRNA plas-
mids. Down-regulation of RhoA mRNA levels by >80% did not
enhance axon growth of DRG neurons measured at 2 and 3 days
after transfection (Figures 4A,B). The efficacy of the silencing
approach was confirmed by grouped cell qRT-PCR of DRG neu-
rons (Figure 4A) and protein blotting of shRNA transfected PC12
cells (data not shown).
Subsequently, we overexpressed wild-type RhoA, constitu-
tively active (V14) or dominant-negative (N19) RhoA constructs
in DRG neurons. Transfection of plasmids encoding dominant
negative RhoA did not enhance axon outgrowth, but, in fact,
decreased the maximal axonal length in comparison to control
transfected neurons (Figure 4C). Overexpression of wild-type or
constitutively active RhoA did not show any effect on maximal
axonal distance. None of the constructs had an impact on total
axonal length, but V14 and N19 partly affected neuronal viability.
THE C3bot MUTANT E174Q STILL PROMOTES AXONAL OUTGROWTH
The lack of stimulation of axon growth upon blockade of RhoA
prompted us to investigate the role of RhoA for regenerational
outgrowth of sensory neurons in more detail. Specifically, we
assayed a point mutant of C3bot, E174Q, which lacks Rho
inhibitory activity, for its potential influence on axon growth.
As illustrated in Figure 5A bath application of C3E174Q leads to
increased total axonal outgrowth and branching. Although the
overall effect was weaker than with C3bot, this finding was unex-
pected given that the Rho inhibitory activity of the mutant is
virtually lost as demonstrated in Figures 5B,C. In contrast, pull
down assays revealed dramatically reduced RhoA-GTP levels fol-
lowing 24 h of bath application of recombinant C3bot. In parallel,
the RhoA protein wasmodified by ADP-ribosylation as illustrated
by a shift in molecular weight (see also Just et al., 2011) or by
direct labeling of RhoA with radioactive ADP in cell-free assays
(Figure 5C).
C3bot STIMULATES ERK AND Akt PATHWAYS INDEPENDENTLY FROM
RhoA INACTIVATION
In an approach to analyze possible signaling mechanisms under-
lying the Rho independent effect on axon outgrowth by C3bot
and C3E174Q, we assayed for upregulation of pERK, pAkt, and
pSTAT3. All three signaling molecules are profoundly implicated
in the regulation of axonal outgrowth and branching in sensory
neurons (Markus et al., 2002; Zhou and Snider, 2006). We per-
formed a C3bot time course experiment and found that pERK,
i.e., pERK42 and pERK44, is upregulated by about 2-fold and
Frontiers in Cellular Neuroscience www.frontiersin.org October 2012 | Volume 6 | Article 43 | 3
Auer et al. Rho-independent signaling by C3
FIGURE 3 | Neuronal transfection of a plasmid encoding for C3 (pEGF-C3) and
a marker plasmid encoding DsRed does not stimulate axonal growth (A).
Axon growth between day 2 and day 3 (results presented as delta) after
transfection is followed cell-by-cell. The maximal axonal distance of C3
overexpressing neurons decreases compared to control DsRed-transfected
neurons. No alterations in the total axonal length and the number of branch
points are observed (total number of neurons per group >110, three
independent experiments, mean ± SEM; ∗p < 0.05). Quantitative RT-PCR of
transfected rat pheochromocytoma (PC12) cells and DRG neurons (20 cells
per experiment) reveals C3 mRNA expression (B). C3-transfected PC12 and
SY5Y human neuroblastoma cells express high levels of C3 protein (C). Pure
C3bot served as positive control.
pAkt by about 2.5-fold within the first hour of C3bot incubation
with a peak at around 30min (Figure 6A). Immunofluorescence
labeling confirmed increased levels of pERK and pAkt in treated
neurons (Figure 6B). pSTAT3 did not show any regulation by
C3bot (data not shown). C3E174Q, on the other hand, lead to a
significant upregulation of pERK activity by about 1.6-fold after
3.5 h, but lacked any effect on pAkt. The kinetics of C3E174Q
affecting pERK activity were slower than of C3bot, which might
be due to C3bot, but not C3E174Q, harboring a membrane per-
meable cp-tag (Winton et al., 2002). We then performed a time
course assay to test whether upregulation of pERK and pAkt by
C3bot is dependent on its well-known Rho inhibitory activity. In
contrast to cell free assays, inactivation of RhoA by C3bot in DRG
neurons occurs only after long-term incubation, but definitely
not before 2.5 h, thus ruling out a causal link between inacti-
vation of RhoA and activation of pERK and pAkt (Figure 6C).
In order to assess the cell type specificity of this novel signal-
ing activity of C3bot we then stimulated hippocampal neurons
with C3bot and determined the status of pERK and pAkt. Levels
of pERK, but not pAkt, were upregulated by C3bot 48 h after
treatment indicating some cell type specificity of C3bot action, at
least when comparing peripheral with central neurons (Figure 7).
Shorter treatments with C3bot were not effective in hippocam-
pal neuron culture. Taken together, we suggest a model in which
C3bot induces kinase activation independently from inactivation
of RhoA (Figure 8).
DISCUSSION
In the present study, we provide evidence for an axonotrophic
function of C3bot that is independent of RhoA inhibition in
peripheral sensory neurons obtained from adult DRG. Inhibition,
down-regulation or interfering with RhoA using a dominant-
negative mutant did not enhance axon initiation, elongation,
or branching suggesting a minor role, if any, of RhoA in axon
growth of DRG neurons on a growth-promoting substrate. This
outcome was surprising, since inhibition of the RhoA effector,
ROCK, clearly promotes sensory axon regeneration on growth
promoting or inhibitory substrates in vitro and in vivo (Borisoff
et al., 2003; Fournier et al., 2003; Hiraga et al., 2006; Cheng
et al., 2008). However, as summarized in a recent review (Auer
et al., 2011), active RhoA influences various signal transduction
pathways not only involved in negative regulation of axon regen-
eration, but also in stimulating axon growth, for example, via
activation of mDia1 (Arakawa et al., 2003). Furthermore, cel-
lular context and developmental stage of the neuronal model
need to be considered. For example, overexpression of dominant-
negative N19RhoA increased neurite extension in neuronal cell
lines (Kranenburg et al., 1997; Sebok et al., 1999; Jeon et al.,
2012), but decreased axon length and branching of embry-
onic hippocampal neurons seeded onto a growth-promoting
substrate (Ahnert-Hilger et al., 2004). As we show here, this
construct was ineffective in adult DRG neurons with regard to
axon outgrowth. Recently, Leslie et al. deleted RhoA specifically
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FIGURE 4 | Transfection of shRNA plasmids (also encoding EGFP)
specifically targeting RhoA does not alter axonal growth of DRG neurons
between day 2 and day 3 (results presented as delta; A,B). Controls are
transfected with respective scrambled shRNA (total number of neurons
per group >60, three independent experiments, mean ± SEM).
Quantitative RT-PCR reveals downregulation of RhoA mRNA in DRG
neurons following RhoA shRNA transfection (pool of 20 neurons per
PCR, n = 3). DRG neurons transfected with a plasmid encoding
dominant negative (DN) RhoA together with a marker plasmid exhibit a
decreased maximal axonal distance with a statistically unaltered total
axonal length (C). Constitutively active (CA) or wildtype RhoA do not
alter axonal growth in fluorescent cells (total number of neurons per
group >77, three independent experiments, mean ± SEM; ∗∗p < 0.01,
∗∗∗p < 0.005).
in DRG neurons using RhoA-floxed mice under a Wnt1-Cre
driver (Leslie et al., 2012). Supporting our in vitro data, they
found that peripheral projections of sensory neurons are nor-
mal, and no detectable defects in the central projections of either
cutaneous or proprioceptive sensory neurons were observed
in the RhoA deficient mice. They also revealed that RhoA is
not required for Sema3A-mediated axonal repulsion of sensory
neurons.
The role of C3bot has been extensively investigated in CNS
injury models with regard to the limited regeneration due to
the presence of myelin-derived inhibitors. Cerebellar granule
cells treated with C3bot revealed enhanced neurite outgrowth
on substrate-bound axon growth inhibitors, such as Nogo-66
or MAG (Niederost et al., 2002). Moreover, sensory neurons
treated with C3bot did not exhibit growth cone collapse upon
contact with oligodendrocytes and enhanced neurite outgrowth
on myelin (Jin and Strittmatter, 1997; Fournier et al., 2003).
Recently, Zhou et al. (2012) expressed C3bot in cervical DRG
neurons via herpes simplex virus (HSV) mediated gene transfer
in vivo. Following unilateral dorsal root crush, large myelinated
axons extending from primary afferent neurons regenerated into
the dorsal columns over several segments of the spinal cord
suggesting that C3bot has the potential to overcome myelin-
inhibition of sensory axons in the CNS. However, overexpres-
sion of full-length C3bot in hippocampal (Ahnert-Hilger et al.,
2004) or sensory neurons (this study) was not stimulating
axonal outgrowth, whereas treatment with enzymatically inactive
C3bot or with peptide fragments derived from C3bot promoted
axon growth and regeneration in the CNS (Boato et al., 2010;
Just et al., 2011).
We demonstrate here that full-length C3bot rapidly induced
regeneration-associated signaling pathways in primary neurons
(Figure 6). The effects were weaker, but reminiscent of those
induced by neurotrophic factors, such as FGF-2 or NGF, that
are released upon peripheral nerve injury and enhance axon
regeneration via binding to receptor tyrosine kinases followed by
activation of the ERK (MAPK) and PI3K/Akt pathways (Zhou
and Snider, 2006; Hausott et al., 2008). The growth factor induced
Frontiers in Cellular Neuroscience www.frontiersin.org October 2012 | Volume 6 | Article 43 | 5
Auer et al. Rho-independent signaling by C3
FIGURE 5 | Compared to vehicle-treated control neurons mutant C3E174Q
(1μg/ml, non-permeable) stimulates axonal growth, but does not improve
axonal elongation (A; total number of neurons per group >240, three
independent experiments, mean ± SEM; ∗p < 0.05). Pull down assays
(B) demonstrate strongly reduced RhoA-GTP levels one day after treatment
with C3bot, but only slightly with C3E174Q. A shift in molecular weight of total
RhoA reveals modification by ADP-ribosylation. In vitro cell-free assays with
radioactive ADP confirm inability of C3E174Q to inactivate RhoA directly (C).
decrease of RhoA-GTP levels observed in immortalized cell lines
has been suggested to be relevant for these effects. NGF signaling
via TrkA stimulates PI3K, which in turn increases Rac1 activity
to induce RhoA inactivation (Nusser et al., 2002). In addition,
the activation of FGFR1, the primary neuronal FGF receptor,
and subsequent phosphorylation of the docking protein FRS2β
releases Rnd1, which then decreases RhoA-GTP loading (Harada
et al., 2005). Other studies performed in sensory neurons con-
firmed the link between the tyrosine-kinase activated subunit
p110δ of PI3K and Rho inactivation (Eickholt et al., 2007).
However, as demonstrated here, the inactivation of neuronal
RhoA by growth factors was neither required nor sufficient for
axon regeneration of adult sensory neurons in vitro.
The lack of axon growth promoting activities of full-length
C3bot in the sciatic nerve lesion model in vivo (Huelsenbeck et al.,
2012) may be attributed to C3bot mediated inhibition of RhoA in
non-neuronal cells which possibly counteracted the axonotrophic
effects we observed in vitro in a sensory neuron culture. Indeed,
Schwann cell migration and axonal ensheathment are affected by
perturbation of Rho activity (Sepp and Auld, 2003). In conclu-
sion, although RhoA plays a central role in mediating the effects
of myelin-derived inhibitors on axon outgrowth, its function may
be limited during axon regeneration in a growth-promoting envi-
ronment presented to a peripheral nerve. Nevertheless, C3bot does
stimulate axon outgrowth of adult sensory neurons, but not via
blockade of RhoA but, presumably, via ERK and Akt activa-
tion (Figure 8). Our data presented herein support the view of a
non-enzymatic mode of action of C3bot (Höltje et al., 2009; Loske
et al., 2012).
MATERIALS AND METHODS
CELL CULTURES AND TRANSFECTIONS
PC12 cells stably overexpressing fibroblast growth factor receptor
(FGFR1; Hausott et al., 2008) were cultured on collagen-coated
dishes in RPMI medium supplemented with 10% horse serum,
5% fetal bovine serum, antibiotics, and antimycotics (all from
GIBCO Invitrogen). SH-SY5Y neuroblastoma cells were cultured
in RPMI medium supplemented with 10% fetal bovine serum,
1% L-glutamine, antibiotics, and antimycotics. For transfection
cells were washed off the dish, triturated for 5min and cen-
trifuged at 800 rpm for 5min at 4◦C. For transfection the cell
pellet was resuspended in 100μl RPMI medium and a total
amount of 3μg of plasmid was added before nucleofection (pro-
gramU-029 for PC12 cells, A-023 for SH-SY5Y cells). Transfected
cells were seeded onto optical dishes (ibidi) for fluorescence
microscopy or onto standard plastic culture dishes for biochemi-
cal experiments.
DRG were dissected from CO2-euthanised young adult
Sprague-Dawley rats (Charles River Laboratories). About 45 DRG
per rat were collected in ice-cold RPMI supplemented with antibi-
otic/antimycotic and transferred into plastic dishes under a lam-
inar flow. DRG were incubated in collagenase type I (5000U/ml,
1 h, 37◦C, GIBCO Invitrogen) followed by digestion with trypsin
(0.05%, 15min, 37◦C, GIBCO Invitrogen). Two washes in 3ml
of serum containing medium (RPMI with 10% horse serum,
5% fetal bovine serum, and antibiotic/antimycotic) inhibited
trypsin activity. The softened DRG were transferred to culture
medium (RPMI supplemented with B27) and gently triturated
4–6 times using fire-polished Pasteur pipettes with decreasing
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FIGURE 6 | Quantitative Western blotting experiments employing infrared
dye labeled secondary antibodies demonstrate rapid activation of ERK
and Akt signaling pathways in dissociated adult DRG neurons after
application of C3bot or C3E174Q (A; each 1μg/ml). FGF-2 (100 ng/ml) is
used as a positive control and densitometry values are normalized to
GAPDH and vehicle treated control values (n = 3, mean ± SD; ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.005). Immunofluorescence labeling of pERK and
pAkt (red) in control DRG neurons and in neurons treated with C3bot or
FGF-2 (B; 1μg/ml for 30min; tubulin in green and Hoechst staining in
blue). Note that treatment with C3bot for 2.5 h does not reduce
RhoA-GTP loading suggesting a RhoA-independent activation of ERK and
Akt (C).
opening diameter. The cell suspension was seeded onto plastic
dishes pre-coated with poly-D-lysine hydrobromide (100μg/ml,
overnight, 37◦C, Sigma-Aldrich) and laminin (5μg/ml, >4 h,
37◦C, Sigma-Aldrich).
For each transfection approximate 20 DRG were used.
Following trituration, the cell suspension was centrifuged
(800 rpm, 5min, 4◦C) and pellets were each dissolved in 100μl
Rat Neuron Nucleofector solution (Lonza). Five μg of plasmid
DNA was added (for co-transfection experiments the fluorescent
marker plasmid was applied 1:2) and suspensions were electropo-
rated using Amaxa’s nucleoporation protocol (O-003) followed
by seeding the transfected neurons onto poly-D-lysine/laminin
pre-coated dishes.
For preparation of hippocampal cultures neurons were pre-
pared from fetal mice at embryonic day 16 (E16). Dissected pieces
of hippocampi were rinsed with PBS, then with dissociation
medium (MEM supplemented with 10% fetal calf serum, 100 IE
insuline/l, 0.5mM glutamine, 100U/ml penicillin/streptomycin,
44mM glucose, and 10mM HEPES buffer) and dissociated
mechanically. Sedimented cells were resuspended in starter
medium (serum-free neurobasal medium supplemented with
B27, 0.5mM glutamine, 100U/ml penicillin/streptomycin and
25μM glutamate) and plated at a density of 1 × 105 cells/well
onto 6-well plates precoated with poly-L-lysine/collagen (all
chemicals from GIBCO Invitrogen).
All experiments were in accordance with the statement of eth-
ical standards concerning animal care of the guidelines of the
National Institutes of Health and the ethical commission of the
Austrian Ministry of Science.
NEURON LABELING AND AXON MEASUREMENTS
In experiments with low transfection efficiencies (<15%) the
same DRG neuron was measured twice at 48 and 72 h after trans-
fection. Some neurons were negatively affected by electroporation
(exhibiting a reduced total axon length at day 3 when compared to
day 2) and excluded from further analysis. For immunostaining,
neurons were fixed for 10min with 4% paraformaldehyde at 4◦C,
permeabilized with 0.5% Triton X-100 and blocked with 0.3%
goat serum (in PBS) for 5min. After rinsing in PBS primary anti-
bodies raised against neurofilament (1:400; Sigma-Aldrich) were
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FIGURE 7 | Cultured murine hippocampal neurons treated with C3bot for
48 h stained for microtubule associated protein 2 (A) and subjected to
Western blotting (B). Effects of C3bot treatment on ERK and Akt
phosphorylation were evaluated. C3 antiserum is used to confirm
presence of C3bot. Quantification of protein expression reveals a
significant promotive effect of C3bot on both ERK42 and ERK 44
phosphorylation (C; total number of neurons per group >50, three
independent experiments, mean ± SEM; ∗p < 0.05).
applied overnight at 4◦C and detected by secondary antibodies
conjugated to Alexa fluorochromes. For staining of hippocampal
neurons a polyclonal antiserum against microtubule associated
proteins 2 (MAP2, Chemicon) was used. Neurofilament positive
neurons were documented by inverted fluorescence microscopy
(Zeiss Axiovert 100) equipped with a SPOT RT digital cam-
era connected to a PC. Morphometry software (MetaMorph®,
Visitron Systems) was applied to measure the longest of all vec-
tors from the centroid of the cell body to the growth cones
(the maximal axonal distance, MD), the total axonal length and
the number of all axonal branch points per neuron. All mor-
phologically intact neurons per dish with MDs ≥ 50μm were
documented by high-resolution CCD cameras followed by image
correction for background and cell body fluorescence.
PLASMIDS AND C3bot PREPARATIONS
pEGF-C3bot was a kind gift of K. Kosonen and M. Courtney
(Kuopio, Finland). Plasmids encoding dominant negative, con-
stitutively active and wild type RhoA have been described before
(Ahnert-Hilger et al., 2004). For down-regulation of RhoA
shRNA plasmid (pCMV-EGFP-U6-rRhoA618) was used (top
strand of the insert 5′ to 3′ : GAT CCG TGC TGT TTA TTA
ATC TTA TTC AAG AGA TAA GAT TAA TAA ACA GCA CTT
TTT TGAATT CA). Clostridium botulinum derivedmutant C3bot
(C3 E174Q, carrying a point mutation from glutamate to glu-
tamine at AA 174) was cloned into pGEX-2T expression vectors
and expressed as recombinant glutathione S-transferase fusion
protein in Escherichia coli TG1. The GST tag was removed by
thrombin cleavage. C3bot (membrane permeable) was purchased
from Cytoskeleton.
RT-PCR
RNA extraction was performed applying the RNeasy Mini Kit
(Qiagen) including DNase-digestion. The transcription of RNA
to cDNA was carried out with the iScriptTM cDNA Synthesis Kit
(Biorad) according to the manufacturer’s instructions with 5min
at 25◦C, 30min at 42◦C, and 5min at 85◦C resulting in 20μl of
cDNA. Quantitative real time (qRT) PCR of cDNA from cultured
primary sensory rat DRG neurons or PC12 cells was performed
on Biorad’s iCycler in a final volume of 25μl with 12.5μl iQ
SYBR Green Supermix (Biorad; containing 40mM Tris-HCl,
100mM KCl, 6mM MgCl2, 0.4mM of each dNTP, 50U/ml iTaq
DNA polymerase, SYBR Green I, 20 nM fluorescein, and stabi-
lizers), 7.5μl sterile water, 0.2μl of each primer (20μM), and
1μl cDNA template (3min denaturing step followed by 40 cycles
30 s at 95◦C and 60 s at 60◦C). The following primers were used:
hypoxanthine phosphoribosyltransferase 1 (HPRT1) as a house
keeping gene control (forward TGACACTGGCAAAACAATGCA
and reverse GGTCCTTTTCACCAGCAAGCT), C3 (forward
AGCAAAAGGCTCAAAGGCAGGAT and reverse GCTGTGCC
CATCATTGTTGCTGT), RhoA (forward CTCATAGTCTTCAGC
AAGGACCAGTT and reverse ATCATTCCGAAGATCCTTC
TTGTT).
The verification of PCR products was performed with both
melt-curve analysis (Biorad iCycler iQ software) and elec-
trophoretic separation on a 2% agarose gel containing 0.1%
ethidium bromide with subsequent visualization of DNA bands
by ultraviolet transillumination.
Grouped cell qRT-PCR was based on 20 cells per group.
Micromanipulator-supported microscopy was used to pick indi-
vidual single cells under visual control. Cells were sucked into
a glass capillary with a diameter of approximately 20μm, and
released into lysis/binding buffer (DYNAL Dynabeads mRNA
direct micro kit). The mRNA was isolated by magnetic sepa-
ration on 10μl prewashed magnetic beads, washed, eluted in
TrisHCl and solid-phase cDNA synthesis was run according to
the manufacturers protocol, using 4μl reaction mix, 1μl reverse
transcriptase, and 10μl nuclease-free water per sample (iSCRIPT
Biorad). Fiveμl of cDNA and 12.5μl of iQ SYBRGreen Supermix
(Biorad) were diluted with destilled water to a final volume
of 25μl and administered to qPCR. The applied steps of the
polymerase chain reaction and primers in use are stated above.
WESTERN BLOTTING
For Western blotting experiments cells were washed twice in
ice cold PBS, scraped, and lysed in RIPA II lysis buffer con-
sisting of 50mM Tris/HCl pH 7.4, 500mM NaCl, 1% NP-40,
0.5% Na-DOC, 0.1% SDS, 0.05% NaN3, protease inhibitor cock-
tail Complete (1:100, Roche Applied Science) and phosphatase
inhibitor cocktails (1:100, Sigma). Lysates were incubated on ice
for 45min and vortexed every 10min, sonicated and centrifuged
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FIGURE 8 | The PI3K/Akt- and Ras/Raf/ERK-signaling pathways are activated
by receptor tyrosine kinases upon ligand binding. Both pathways are crucial
for axon outgrowth during development and regeneration. The activation of
the ERK-machinery is implicated in neuronal survival and elongative axon
growth following injury. PI3K/Akt signaling is central to the regulation of
cytoskeletal proteins and is linked to neuronal survival and axonal branching.
Small GTPases are under control of PI3K signaling and mediate the effects on
microtubule dynamics and actin polymerization. Our observations challenge
the prevalent view of an inhibitory effect of RhoA activation on axonal
regeneration in adult sensory neurons. Pharmacological inhibition of RhoA
with C3bot does not appear to underlie the positive effects of C3bot on axonal
regeneration. In contrast, available data suggest Rho independent means of
C3bot involving ERK/Akt signaling mechanisms probably by a non-enzymatic
mode of action of C3bot.
(14,000 rpm, 20min, 4◦C) in order to collect the supernatant.
As a positive control 0.1μg of C3bot was used. Homogenates
dissolved in 4× Laemmli buffer (0.25M Tris pH 6.8, 8% SDS,
40% glycerol, bromphenol blue, 20% β-mercaptoethanol) were
denaturated at 95◦C for 5min, loaded on 10% or 15% polyacry-
lamide gels, separated via electrophoresis at 100V, and blotted
onto polyvinylidene difluoride (PVDF) membranes. These were
blocked with 5% skim milk (Merck) and incubated overnight
at 4◦C with antibodies against RhoA (1:1000, Santa Cruz) in
1% skim milk in PBS containing 0.05% Tween20 (PBS-Tween).
Antibodies (all from Cell Signaling) against pAkt (1:2000), pERK
(1:1000), pSTAT3 (1:1000), Akt (1:2000) or ERK (1:2000) were
applied in PBS-Tween containing 5% BSA, antibodies against
C3 (1:5000; Hoffmann et al., 2008) in PBS-Tween containing
2% milk and 3% BSA. Gross protein load was assessed using
Ponceau red, while GAPDH bands served as loading controls
(1:1000; Santa Cruz). Secondary horseradish peroxidase-linked
anti rabbit or anti mouse antibody (Pierce; 1:10,000) was detected
by the enhanced chemiluminescence Western blotting detection
system (Pierce). Quantitative Western Blotting was carried out
using secondary IR 800 antibody (anti mouse) and IR 680 anti-
body (anti rabbit) from LI-COR, both applied at 1:2500 in 5%
BSA, and detected with an Odyssey® Infrared Imaging System
(LI-COR). Quantification of signal intensities was performed
with the Odyssey® software.
RhoA-GTP PULLDOWN
Approximately 45 DRG were collected per sample. Dissociated
neurons were cultured for 24 h with or without treatment of C3
enzyme as indicated, followed by protein extraction at 4◦C as
described (Schweigreiter et al., 2004). Briefly, cells were washed
twice with ice-cold TBS and lysed with ice-cold lysisbuffer [500μl
per sample; 50mM Tris pH 7.2, 1% Triton X-100, 150mM NaCl,
10mM MgCl2, plus freshly added protease inhibitor cocktail
Complete (Roche; 1:100)]. Lysed cells were scraped, collected into
a pre-cooled Eppendorf tube and centrifuged at 14,000 rpm at
4◦C for 5min. Supernatants were divided into a major portion
dedicated to the pull-down of RhoA-GTP (about 450μl) and a
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minor portion of 50μl for assessment of total RhoA. RhoA-GTP
was affinity precipitated by incubating with several microgram of
immobilized GST-RBD for 50min at 4◦C. GST-RBD beads were
washed three times (700×g 1min, 4◦C, 500μl lysis buffer) and
elution and denaturation was done with 1× Laemmli buffer at
95◦C for 5min. Samples were electrophoresed in 15% polyacry-
lamide and proteins were transferred onto PVDF membranes,
which were blocked in 1% skimmilk solution and incubated with
anti-RhoA antibody (1:1000).
CELL-FREE ADP RIBOSYLATION ASSAY
Cells were washed with PBS and scraped into 100μl of lysis buffer
(50mM Tris-Cl, pH 7.4, 1% Triton, 10mM NaCl, 5mM MgCl2,
1mM PMSF, 5mM DTT) followed by ultrasonic disruption
on ice. Protein concentrations were measured by the Bradford
method. Cell lysates containing equal amounts of protein were
incubated with recombinant exoenzyme (C3bot or C3E174Q) and
1μCi [32P]NAD (Amersham Life Science), 10mM dithiothreitol,
10mM thymidine, and 5μM NAD at 37◦C for 20min. The reac-
tion was terminated by addition of Laemmli sample puffer and
then incubated at 95◦C for 10min. Samples were resolved by SDS-
PAGE on 15% gels, and the ADP-ribosylated Rho was analyzed by
phosphorImaging.
STATISTICS
Values are expressed as means ± SD or SEM (as indicated in fig-
ure legend). Each experiment was performed at least three times.
Graph Pad Prism 5 software was used to perform graphics and to
analyze statistical significance (Student’s t-test, One-Way or Two-
Way ANOVA with Tukey post-test if appropriate). P-values below
0.05 were considered statistically significant.
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